CEND1 deficiency induces mitochondrial dysfunction and cognitive impairment in Alzheimer's disease

Cell Death Differ. 2022 Dec;29(12):2417-2428. doi: 10.1038/s41418-022-01027-7. Epub 2022 Jun 22.

Abstract

Alzheimer's disease (AD) is the most common form of neurodegenerative disease featured with memory loss and cognitive function impairments. Chronic mitochondrial stress is a vital pathogenic factor for AD and finally leads to massive neuronal death. However, the underlying mechanism is unclear. By proteomic analysis, we identified a new mitochondrial protein, cell-cycle exit and neuronal differentiation 1 (CEND1), which was decreased significantly in the brain of 5xFAD mice. CEND1 is a neuronal specific protein and locates in the presynaptic mitochondria. Depletion of CEND1 leads to increased mitochondrial fission mediated by upregulation of dynamin related protein 1 (Drp1), resulting in abnormal mitochondrial functions. CEND1 deficiency leads to cognitive impairments in mice. Overexpression of CEND1 in the hippocampus of 5xFAD mice rescued cognitive deficits. Moreover, we identified that CDK5/p25 interacted with and phosphorylated CEND1 which promoted its degradation. Our study provides new mechanistic insights in mitochondrial function regulations by CEND1 in Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Cognitive Dysfunction* / genetics
  • Cognitive Dysfunction* / metabolism
  • Disease Models, Animal
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Transgenic
  • Mitochondria / metabolism
  • Nerve Tissue Proteins / metabolism
  • Neurodegenerative Diseases* / metabolism
  • Proteomics

Substances

  • Amyloid beta-Peptides
  • Cend1 protein, mouse
  • Membrane Proteins
  • Nerve Tissue Proteins